Vaccinia virus-interleukin 12 gene therapy - MultiVirAlternative Names: VV-IL12
Latest Information Update: 09 Aug 2016
At a glance
- Originator MultiVir
- Class Gene therapies
- Mechanism of Action Gene transference
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Preclinical Pancreatic cancer
Most Recent Events
- 30 Mar 2015 Preclinical trials in Pancreatic cancer in USA (Parenteral)